Alterola Biotech, Inc. (ABTI) 은(는) 상장 기업입니다 헬스케어 섹터의 Drug Manufacturers - Specialty & Generic 산업에서 운영. 본사 소재지는 Birkenhead, 영국. 현재 CEO는 David John Hitchcock.
ABTI 을(를) 보유 IPO 날짜 2010-05-05, 1 명의 정규직 직원, 에 상장 Other OTC, 시가총액 $7.44M.
Alterola Biotech, Inc., a pharmaceutical company, engages in the development of cannabinoid and cannabinoid-like molecules. It focuses on the development of regulated human and animal health pharmaceuticals and regulated food products; production of active pharmaceutical ingredients and food-grade ingredients; and formulation and drug delivery for improved bioavailability, solubility, and stability. The company is based in Birkenhead, the United Kingdom.
